This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: International Stem Cell Corporation. Active years: 2010-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Santa Monica, CA (US) (2018)
- Pacific Palisades, CA (US) (2010 - 2022)
Company Filing History:
Years Active: 2010-2022
Title: Innovations in Stem Cell Research by Elena S Revazova
Introduction
Elena S Revazova is a prominent inventor based in Pacific Palisades, California. She has made significant contributions to the field of stem cell research, holding a total of four patents. Her work focuses on innovative methods for producing human stem cells, which have important implications for medical science.
Latest Patents
Revazova's latest patents include groundbreaking methods for parthenogenically activating human oocytes to produce neuronal cells. These methods involve manipulating tension and using specific inhibitors to isolate inner cell masses from activated oocytes. Additionally, she has developed protocols for generating patient-specific stem cell lines derived from human parthenogenetic blastocysts. These lines exhibit typical human embryonic stem cell characteristics and have been shown to form teratomas when injected into immunodeficient animals. Her work minimizes the use of animal-derived components, enhancing the clinical applicability of these stem cells.
Career Highlights
Elena Revazova is associated with the International Stem Cell Corporation, where she continues to advance her research. Her innovative approaches have positioned her as a leader in the field of stem cell technology.
Collaborations
Revazova collaborates with notable colleagues, including Leonid N Kuzmichev and Jeffrey D Janus, to further her research initiatives.
Conclusion
Elena S Revazova's contributions to stem cell research are paving the way for new medical advancements. Her innovative patents and collaborative efforts are crucial for the future of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile